Bortezomib/dexamethasone

Bortezomib/dexamethasone is a combination drug against multiple myeloma.^[1] When bortezomib is used by the trade name Velcade, the combination is called Vel/Dex (or Vel-Dex or Veldex). Bortezomib is a proteasome inhibitor and dexamethasone is a corticosteroid.

Bortezomib/dexamethasone

Combination of
Bortezomib	Proteasome inhibitor
Dexamethasone	Corticosteroid
Clinical data
Trade names	Vel/Dexm, Vel-Dex, and Veldex
Legal status
Legal status	US: ℞-only